Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

116 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q2 2025.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 166M shares of 266M outstanding shares and own 62.34% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (27.1M shares), Blackstone Inc. (20.5M shares), MAK CAPITAL ONE LLC (17M shares), Deep Track Capital, LP (16.9M shares), Syncona Portfolio Ltd (16.6M shares), ARMISTICE CAPITAL, LLC (12M shares), TFG Asset Management GP Ltd (9.5M shares), FMR LLC (7.11M shares), Frazier Life Sciences Management, L.P. (4.62M shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (3.61M shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.